New ipo again_老虎社区_美港股上老虎

Razak
2021-07-02

New ipo again

GIC-backed clinical trial firm WCG reveals revenue jump in IPO filing

(Reuters) -WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign weal

GIC-backed clinical trial firm WCG reveals revenue jump in IPO filing

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":158765064,"tweetId":"158765064","gmtCreate":1625182722258,"gmtModify":1631884082073,"author":{"id":3577134043689710,"idStr":"3577134043689710","authorId":3577134043689710,"authorIdStr":"3577134043689710","name":"Razak","avatar":"https://static.tigerbbs.com/fb3aaeddad6ac1bdd8da9f5841c37524","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>New ipo again</p></body></html>","htmlText":"<html><head></head><body><p>New ipo again</p></body></html>","text":"New ipo again","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/158765064","repostId":1124561643,"repostType":4,"repost":{"id":"1124561643","kind":"news","pubTimestamp":1625181907,"share":"https://www.laohu8.com/m/news/1124561643?lang=&edition=full","pubTime":"2021-07-02 07:25","market":"us","language":"en","title":"GIC-backed clinical trial firm WCG reveals revenue jump in IPO filing","url":"https://stock-news.laohu8.com/highlight/detail?id=1124561643","media":"Reuters","summary":"(Reuters) -WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign weal","content":"<p>(Reuters) -WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign wealth fund GIC, filed for an initial public offering (IPO) in the United States on Thursday and revealed a jump in its quarterly revenue.</p>\n<p>The company, which also counts buyout firm Leonard Green &amp; Partners LP among its investors, plans to list on the Nasdaq.</p>\n<p>WCG was valued at $3.1 billion when Leonard Green took a stake in the company in 2019, Reuters reported at the time. Private equity firm Arsenal Capital Partners is also an investor in the firm which helps clients reduce the time and cost of enrolling patients in clinical trials.</p>\n<p>The company’s revenue jumped by a third to $137.6 million in the three months ended March 31, its filing showed. Net loss came in at $20.6 million from $30.1 million last year.</p>\n<p>Princeton, New Jersey-based WCG is looking to issue into an IPO market which has been on a record run, helped by the U.S. Federal Reserve’s easy money policy and unprecedented government stimulus.</p>\n<p>Goldman Sachs, Morgan Stanley and BofA Securities are among the underwriters for WCG’s IPO.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GIC-backed clinical trial firm WCG reveals revenue jump in IPO filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGIC-backed clinical trial firm WCG reveals revenue jump in IPO filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-02 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/wcg-ipo/update-1-gic-backed-clinical-trial-firm-wcg-reveals-revenue-jump-in-ipo-filing-idUSL3N2OD44G><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign wealth fund GIC, filed for an initial public offering (IPO) in the United States on Thursday and ...</p>\n\n<a href=\"https://www.reuters.com/article/wcg-ipo/update-1-gic-backed-clinical-trial-firm-wcg-reveals-revenue-jump-in-ipo-filing-idUSL3N2OD44G\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://www.reuters.com/article/wcg-ipo/update-1-gic-backed-clinical-trial-firm-wcg-reveals-revenue-jump-in-ipo-filing-idUSL3N2OD44G","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124561643","content_text":"(Reuters) -WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign wealth fund GIC, filed for an initial public offering (IPO) in the United States on Thursday and revealed a jump in its quarterly revenue.\nThe company, which also counts buyout firm Leonard Green & Partners LP among its investors, plans to list on the Nasdaq.\nWCG was valued at $3.1 billion when Leonard Green took a stake in the company in 2019, Reuters reported at the time. Private equity firm Arsenal Capital Partners is also an investor in the firm which helps clients reduce the time and cost of enrolling patients in clinical trials.\nThe company’s revenue jumped by a third to $137.6 million in the three months ended March 31, its filing showed. Net loss came in at $20.6 million from $30.1 million last year.\nPrinceton, New Jersey-based WCG is looking to issue into an IPO market which has been on a record run, helped by the U.S. Federal Reserve’s easy money policy and unprecedented government stimulus.\nGoldman Sachs, Morgan Stanley and BofA Securities are among the underwriters for WCG’s IPO.","news_type":1},"isVote":1,"tweetType":1,"viewCount":189,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NGD"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":11,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}

GIC-backed clinical trial firm WCG reveals revenue jump in IPO filing

评论（1）

热议股票